GPT and metabolic dysfunction-associated steatotic liver disease: Furthermore, some researchers have revealed that the AST/ALT ratio may also be useful for assessing disease risks, such as NAFLD, diabetes mellitus, hyperinsulinemia, cardiovascular disease, and metabolic syndrome (14–17).